Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jiangsu Cancer Institute & Hospital
China Medical University, China
Mayo Clinic
Trans Tasman Radiation Oncology Group
National Cancer Institute (NCI)
Shanghai Pulmonary Hospital, Shanghai, China
Shanghai Junshi Bioscience Co., Ltd.
National Cancer Institute (NCI)
Biotheus Inc.
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Shanghai Pulmonary Hospital, Shanghai, China
Shanghai Pulmonary Hospital, Shanghai, China
Hunan Province Tumor Hospital
Peking Union Medical College Hospital
University of Washington
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
University of Washington
Eastern Cooperative Oncology Group
Jiangsu Cancer Institute & Hospital
Tang-Du Hospital
Sichuan Cancer Hospital and Research Institute
University of California, San Francisco
National Cancer Institute (NCI)
Peking Union Medical College Hospital
National Cancer Institute (NCI)
Fudan University
National Cancer Institute (NCI)
Eli Lilly and Company
New Mexico Cancer Research Alliance
Guangzhou Medical University
Oncozyme Pharma Inc.